CompletedNot Applicable

HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)

China620 participantsStarted 2019-11-18

Plain-language summary

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1008). It aims to evaluate the correlation between radiological diagnosis based on HRCT and pathological invasiveness.Investigators observe the radiological features and the correlation with the postoperative pathological findings.

Who can participate

Age range15 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: (1) GGNs on HRCT scan; (2) clinical stage IA; (3) simultaneously no more than three nodules; (5) Age ranging from 15 to 85 years. Exclusion Criteria: (1) pathologically confirmed non-adenocarcinoma; (2) patients who did not receive surgery.

What they're measuring

Sensitivity

Timeframe: Pathologic reports were available, usually 1 month after surgery

Trial details

NCT IDNCT04165759

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-30

View on ClinicalTrials.gov More Adenocarcinoma of Lung trials